Salivary and serum interleukin-17A and interleukin-18 levels in patients with type 2 diabetes mellitus with and without periodontitis

Objective Interleukin (IL)-17A and IL-18 have been proposed to play important roles in periodontitis and type 2 diabetes mellitus (DM), but human data are conflicting. The present study aimed to investigate the roles of IL-17A and IL-18 in periodontitis and DM by measuring salivary and serum levels, respectively. Materials and methods A total of 49 participants with type 2 DM and 25 control subjects without type 2 DM were recruited. A periodontal screening and recording (PSR) index (0, 1–2, 3, and 4) was used to classify whether these subjects had periodontitis. Salivary and serum IL-17A and IL-18 levels were measured by enzyme-linked immunosorbent assay. Multiple linear regression analyses were used to evaluate the associations between these cytokines and clinical parameters. Results Salivary IL-17A levels were not significantly different between patients with DM and controls, however, the levels were significantly higher in controls with periodontitis than those without periodontitis (p = 0.031). Salivary IL-17A levels were significantly associated with the PSR index (β = 0.369, p = 0.011). Multiple linear regression analyses revealed the association of salivary IL-18 levels and fasting plasma glucose (β = 0.270, p = 0.022) whereas serum IL-18 levels were associated with HbA1C (β = 0.293, p = 0.017). No correlation between salivary and serum levels of IL-17A and IL-18 was found. Conclusion Salivary IL-17A was strongly associated with periodontitis, whereas salivary IL-18 was associated with FPG and serum IL-18 was associated with HbA1C. These results suggest the role of these cytokines in periodontal inflammation and DM.

[1]  G. Allam,et al.  The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  H. Okamura,et al.  Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes , 2017, Endocrine connections.

[3]  P. Tekale,et al.  Effect of Periodontal Therapy on Crevicular Fluid Interleukin-18 Level in Periodontal Health and Disease in Central Maharashtra (India) Population. , 2017, The journal of contemporary dental practice.

[4]  D. Zaffe,et al.  How Intraday Index Changes Influence Periodontal Assessment: A Preliminary Study , 2017, International journal of dentistry.

[5]  K. Al-Rubeaan,et al.  Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients , 2017, Scientific Reports.

[6]  T. Morelli,et al.  Gingival crevicular fluid as a source of biomarkers for periodontitis. , 2016, Periodontology 2000.

[7]  D. Zare,et al.  Levels of Interleukin‐18 in Saliva and Gingival Crevicular Fluid in Patients with Chronic Periodontitis and Healthy Subjects , 2016 .

[8]  N. Dutzan,et al.  Characterization of the human immune cell network at the gingival barrier , 2015, Mucosal Immunology.

[9]  U. Gürsoy,et al.  Salivary interleukin‐17 and tumor necrosis factor‐α in relation to periodontitis and glycemic status in type 2 diabetes mellitus , 2015, Journal of diabetes.

[10]  M. Kamal,et al.  Correlation of Toll-like receptor 4, interleukin-18, transaminases, and uric acid in patients with chronic periodontitis and healthy adults. , 2015, Journal of periodontology.

[11]  G. Ramage,et al.  Clinical associations between IL-17 family cytokines and periodontitis and potential differential roles for IL-17A and IL-17E in periodontal immunity , 2014, Inflammation Research.

[12]  M. Qorbani,et al.  Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls , 2014, BioMed research international.

[13]  F. Hughes,et al.  The presence, function and regulation of IL-17 and Th17 cells in periodontitis. , 2014, Journal of clinical periodontology.

[14]  M. Cooper,et al.  New insights into the use of biomarkers of diabetic nephropathy. , 2014, Advances in chronic kidney disease.

[15]  F. Wolf,et al.  Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers , 2016, Clinical Diabetes.

[16]  G. Tirabassi,et al.  Gingival advanced glycation end-products in diabetes mellitus-associated chronic periodontitis: an immunohistochemical study. , 2013, Journal of periodontal research.

[17]  K. Ruxrungtham,et al.  Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients , 2012, AIDS.

[18]  Cindy Munro,et al.  Comparison of Biomarkers in Blood and Saliva in Healthy Adults , 2012, Nursing research and practice.

[19]  Koichi Matsumoto,et al.  Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications , 2012, Acta Diabetologica.

[20]  Roy Taylor,et al.  Periodontitis and diabetes: a two-way relationship , 2011, Diabetologia.

[21]  N. Buduneli,et al.  Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. , 2011, Journal of periodontal research.

[22]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[23]  H. Arnesen,et al.  The role of interleukin-18 in the metabolic syndrome , 2010, Cardiovascular diabetology.

[24]  V. Kuchroo,et al.  Interleukin-17 and type 17 helper T cells. , 2009, The New England journal of medicine.

[25]  G. Garg,et al.  Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease. , 2009, Journal of periodontology.

[26]  A. Shapiro,et al.  Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice , 2009, Diabetes.

[27]  M. Rossi,et al.  Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. , 2009, Oral microbiology and immunology.

[28]  A. Gustafsson,et al.  The Short-Term Effectiveness of Non-Surgical Treatment in Reducing Levels of Interleukin-1β and Proteases in Gingival Crevicular Fluid From Patients With Type 2 Diabetes Mellitus and Chronic Periodontitis. , 2008, Journal of periodontology.

[29]  M. Netea,et al.  Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus , 2008, International Journal of Obesity.

[30]  S. Socransky,et al.  Increased interleukin-18 in gingival crevicular fluid from periodontitis patients. , 2008, Oral microbiology and immunology.

[31]  J. Ellis,et al.  Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production , 2008, The Journal of experimental medicine.

[32]  J. Chan,et al.  Aberrant activation profile of cytokines and mitogen‐activated protein kinases in type 2 diabetic patients with nephropathy , 2007, Clinical and experimental immunology.

[33]  Y. Konttinen,et al.  MMPs, IL-1, and TNF are Regulated by IL-17 in Periodontitis , 2007, Journal of dental research.

[34]  Y. Kadono,et al.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction , 2006, The Journal of experimental medicine.

[35]  David V. Power,et al.  Standards of Medical Care in Diabetes: Response to position statement of the American Diabetes Association , 2006 .

[36]  H. Makino,et al.  Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. , 2005, Diabetes care.

[37]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[38]  D. Kinane,et al.  The potential role of interleukin-17 in the immunopathology of periodontal disease. , 2005, Journal of clinical periodontology.

[39]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[40]  I B Lamster,et al.  Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. , 2000, Periodontology 2000.

[41]  E. Corbet.  Practical periodontal screening and diagnosis. , 1998, International dental journal.

[42]  M. Navazesh,et al.  Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.

[43]  H. Löe.  Periodontal Disease: The sixth complication of diabetes mellitus , 1993, Diabetes Care.

[44]  F. Hughes.  Periodontium and Periodontal Disease , 2015 .

[45]  Primal Ks,et al.  Periodontal Screening and Recording (PSR) Index Scores Predict Periodontal Diagnosis , 2014 .

[46]  A. Shapiro,et al.  Inhibition of Th 17 cells regulates autoimmune diabetes in NOD mice Running Title : A role for Th 17 cells in autoimmune diabetes , 2009 .

[47]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .